Point Of Care Molecular Diagnostics Market
Point Of Care Molecular Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
148
Base Year:
2022
Sep - 2023
Format:
Report Code:
VMR-
Segments Covered
By
Technology Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH), DNA Sequencing, Microarrays, Other Technologies
-
By
Application Type Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications
-
By
End-Use Decentralized Labs, Hospitals, Home-care, Assisted Living Healthcare Facilities, Research Institutes, Other End Uses
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4.1 Billion |
 Revenue 2030:
|
USD 8.2 Billion |
 Revenue CAGR
(2023 - 2030): |
9.1% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Point Of Care Molecular Diagnostics Market Segment Analysis
- Point Of Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Point Of Care Molecular Diagnostics Application Type Outlook (Revenue, USD Million, 2018 - 2030)
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Point Of Care Molecular Diagnostics End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
-
North America Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
-
North America Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- U.S.
- U.S. Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- U.S. Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- U.S. Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- U.S. Point Of Care Molecular Diagnostics Market, by Technology
- Canada
- Canada Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Canada Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Canada Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Canada Point Of Care Molecular Diagnostics Market, by Technology
-
Mexico
- Mexico Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Mexico Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Mexico Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Mexico Point Of Care Molecular Diagnostics Market, by Technology
-
North America Point Of Care Molecular Diagnostics Market, by Technology
- Europe
-
Europe Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
-
Europe Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
-
Europe Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- U. K.
- U.K. Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- U.K. Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- U.K. Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- U.K. Point Of Care Molecular Diagnostics Market, by Technology
- France
- France Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- France Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- France Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- France Point Of Care Molecular Diagnostics Market, by Technology
-
Germany
- Germany Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Germany Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Germany Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Germany Point Of Care Molecular Diagnostics Market, by Technology
-
Italy
- Italy Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Italy Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Italy Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Italy Point Of Care Molecular Diagnostics Market, by Technology
-
Spain
- Spain Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Spain Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Spain Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Spain Point Of Care Molecular Diagnostics Market, by Technology
-
Rest of Europe
- Rest of Europe Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Rest of Europe Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Rest of Europe Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Rest of Europe Point Of Care Molecular Diagnostics Market, by Technology
-
Europe Point Of Care Molecular Diagnostics Market, by Technology
- Asia Pacific
-
Asia Pacific Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
-
Asia Pacific Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
-
Asia Pacific Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- China
- China Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- China Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- China Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- China Point Of Care Molecular Diagnostics Market, by Technology
- Japan
- Japan Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Japan Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Japan Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Japan Point Of Care Molecular Diagnostics Market, by Technology
-
Germany
- Germany Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Germany Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Germany Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Germany Point Of Care Molecular Diagnostics Market, by Technology
-
India
- India Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- India Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- India Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- India Point Of Care Molecular Diagnostics Market, by Technology
-
South Korea
- South Korea Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- South Korea Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- South Korea Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- South Korea Point Of Care Molecular Diagnostics Market, by Technology
-
South East Asia
- South East Asia Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- South East Asia Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- South East Asia Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- South East Asia Point Of Care Molecular Diagnostics Market, by Technology
-
Rest of Asia Pacific
- Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, by Technology
-
Asia Pacific Point Of Care Molecular Diagnostics Market, by Technology
- Latin America
-
Latin America Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
-
Latin America Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
-
Latin America Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Brazil
- Brazil Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Brazil Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Brazil Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Brazil Point Of Care Molecular Diagnostics Market, by Technology
- Argentina
- Argentina Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Argentina Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Argentina Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Argentina Point Of Care Molecular Diagnostics Market, by Technology
-
Rest of Latin America
- Rest of Latin America Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Rest of Latin America Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Rest of Latin America Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Rest of Latin America Point Of Care Molecular Diagnostics Market, by Technology
-
Latin America Point Of Care Molecular Diagnostics Market, by Technology
- Middle East & Africa
-
Middle East & Africa Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
-
Middle East & Africa Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
-
Middle East & Africa Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- GCC Countries
- GCC Countries Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- GCC Countries Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- GCC Countries Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- GCC Countries Point Of Care Molecular Diagnostics Market, by Technology
- South Africa
- South Africa Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- South Africa Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- South Africa Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- South Africa Point Of Care Molecular Diagnostics Market, by Technology
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
- DNA Sequencing
- Microarrays
- Other Technologies
- Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, by Application Type
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
- Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, by End-Use
- Decentralized Labs
- Hospitals
- Home-care
- Assisted Living Healthcare Facilities
- Research Institutes
- Other End Uses
- Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, by Technology
-
Middle East & Africa Point Of Care Molecular Diagnostics Market, by Technology
- North America
FAQ
Frequently Asked Question
What is the global demand for Point Of Care Molecular Diagnostics in terms of revenue?
-
The global Point Of Care Molecular Diagnostics valued at USD 4.1 Billion in 2022 and is expected to reach USD 8.2 Billion in 2030 growing at a CAGR of 9.1%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories (U.S.), Bayer AG (Germany), F. Hoffmann-La Roche AG (Switzerland), Nova Biomedical (U.S.), QIAGEN (Germany), Nipro Diagnostics (Japan), Danaher (U.S.), Bio-Rad Laboratories Inc. (U.S.), bioMérieux (France), Agilent Technologies Inc. (U.S.), Abaxis (U.S.), OraSure Technologies (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.1% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Point Of Care Molecular Diagnostics include
- Increasing prevalence of Infectious diseases and cancer
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Point Of Care Molecular Diagnostics in 2022.
